Kewaunee Scientific (KEQU) Common Equity (2011 - 2026)

Kewaunee Scientific's Common Equity history runs 16 years deep, the most recent figure standing at $72.5 million for Q1 2026.

• In Q1 2026, Common Equity rose 19.29% year-over-year to $72.5 million; the TTM figure through Jan 2026 stood at $72.5 million (up 19.29% YoY), while the FY2025 annual figure was $66.2 million, up 20.97% from the prior year.
• Common Equity was $72.5 million for Q1 2026 at Kewaunee Scientific, up from $69.9 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $72.5 million in Q1 2026 to a low of $34.4 million in Q4 2022.
• Historically, Common Equity has averaged $49.7 million across 5 years, with a median of $44.1 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Common Equity fell 13.45% in 2022, then jumped 46.38% in 2024.
• A 5-year view of Common Equity shows it stood at $34.4 million in 2022, then rose by 22.4% to $42.1 million in 2023, then surged by 40.89% to $59.3 million in 2024, then rose by 17.74% to $69.9 million in 2025, then grew by 3.83% to $72.5 million in 2026.
• The last three Common Equity figures came in at $72.5 million (Q1 2026), $69.9 million (Q4 2025), and $67.1 million (Q3 2025), per Business Quant data.